COSCI
LIVE

Serial Number

79221325

Owner

Cosci Med-Tech Co.Ltd.

Attorney

Simone Chen

Filing Date

Jan 12, 2017

Add to watchlist:

No watchlists yet
View on USPTO

COSCI Trademark

Serial Number: 79221325 • Registration: 5505585

COSCI is a trademark filed by Cosci Med-Tech Co.Ltd. on January 12, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Cosci Med-Tech Co.Ltd. (3 trademarks)

15/F, Building A
Haidian District , CN

Entity Type: 99

Trademark Details

Filing Date

January 12, 2017

Registration Date

July 3, 2018

Published for Opposition

April 17, 2018

Cancellation Date

January 17, 2025

Goods & Services

Medicines for human purposes for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; dietetic foods adapted for medical purposes; air freshening preparations, namely, air purifying preparations, air deodorizing preparations; biological preparations for veterinary purposes for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; pesticides; pharmaceutical preparations for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; chemical preparations for medical purposes for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; injections, namely, injectable pharmaceutical preparations for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; tablets, namely, pharmaceutical tablets for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; raw material medicine, namely, ethers, dextrins, and collodion for pharmaceutical purposes

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Mar 19, 2026 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 4, 2026 INTS
INVALIDATION PROCESSED
Mar 4, 2026 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 17, 2025 INTR
CANCELLED SECTION 71
Jan 17, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 3, 2023 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 26, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 9, 2018 FICS
FINAL DISPOSITION PROCESSED
Oct 9, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 3, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 3, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 17, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 17, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 28, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 15, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 15, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 15, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 15, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 15, 2018 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 14, 2018 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 6, 2018 PBCR
ASSIGNED TO LIE
Feb 22, 2018 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 10, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2018 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 23, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 23, 2018 REAP
REFUSAL PROCESSED BY IB
Jan 6, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 13, 2017 RFCS
REFUSAL PROCESSED BY MPU
Dec 13, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Dec 5, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 1, 2017 RFCR
NON-FINAL ACTION WRITTEN
Nov 30, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 29, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 29, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 23, 2017 REPR